SCHEMBL2808422

SCHEMBL2808422

c1ccc(CN2CCc3n[nH]c4nc(NCCc5ccc(-c6ccccc6)cc5)nc2c34)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX1 Q96LB2 1/20 0.40
HRH4 Q9H3N8 4/20 0.39
HRH1 P35367 3/20 0.39
ESR1 P03372 4/20 0.39
ESR2 Q92731 4/20 0.39
CETP P11597 1/20 0.37
AKT1 P31749 2/20 0.37
MYLK Q15746 2/20 0.37
MAPK14 Q16539 2/20 0.37
ROCK1 Q13464 1/20 0.35
ADRA2B P18089 1/20 0.34
ADRA2C P18825 1/20 0.34
SLC6A2 P23975 1/20 0.34
HRH2 P25021 1/20 0.34
HTR1D P28221 1/20 0.34
HTR2A P28223 1/20 0.34
HTR2C P28335 1/20 0.34
HTR7 P34969 1/20 0.34
HTR2B P41595 1/20 0.34
HTR5A P47898 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2810525 0.92 MRGPRX1 (0.49) MRGPRX1HRH4HRH1ESR1ESR2
SCHEMBL2812298 0.92 CLPP (0.38) HRH4HRH1HRH2HRH3
SCHEMBL14405859 0.91 HRH4 (0.41) MRGPRX1HRH4HRH1ESR1ESR2
SCHEMBL2813867 0.91 CLPP (0.40) MRGPRX1HRH4HRH1ESR1ESR2
SCHEMBL2816666 0.91 KDM4E (0.41) MRGPRX1HRH4HRH1ESR1ESR2
SCHEMBL2813934 0.89 CLPP (0.42) MRGPRX1HRH4HRH1SIGMAR1ADORA3
SCHEMBL2810268 0.89 CLPP (0.42) MRGPRX1HRH4HRH1SIGMAR1ADORA3
SCHEMBL2816646 0.88 CLPP (0.41) MRGPRX1HRH4HRH1ESR1ESR2
SCHEMBL2814261 0.87 CLPP (0.39) MRGPRX1HRH4HRH1ESR1ESR2
SCHEMBL2812207 0.87 MKNK1 (0.42) HRH4HRH1ROCK1OGAMKNK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS DPYD, TYMP, TP53 MRGPRX1 2755/4885HRH4 1891/4885HRH1 2327/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.